BRC News

UCLH and UCL are part of an international consortium awarded a substantial prize to further develop an innovative infectious disease outbreak detection system.

More than nine in ten patients taking part in research at UCLH would consider doing so again and felt valued for their participation, according to a national survey.

Presence of tumour DNA in the blood – a biomarker or indicator of disease first identified by a BRC-supported consortium – can predict which cancer patients are most likely to relapse after having a tumour surgically removed and most likely to benefit from immunotherapy.

Pioneering technology developed by UCL and Africa Health Research Institute (AHRI) could transform the ability to accurately interpret HIV test results.

Members of the public joined an interactive workshop to find out how health data is collected and can be used in research to improve patient care.

UCLH and UCL clinicians and researchers have been recognised in the Queen’s Birthday Honours 2021.

UCL has been ranked highly in leading international university league tables including eighth globally in the 2022 World University Rankings.

Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes, including relapsed/refractory chronic lymphocytic leukaemia (CLL) / small lymphocytic lymphoma (SLL) and mantle cell lymphoma (MCL).

Read the first edition of the NIHR UCLH Clinical Research Facility’s (CRF) early phase cancer trials newsletter.

UCLH is the first site in the UK to recruit to an international vaccine study looking at the safety, tolerability and immune response generated by the Pfizer-BioNTech Covid-19 vaccine in healthy pregnant women.

A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 variant first discovered in India are on average lower than those against previously circulating variants in the UK.

People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.

Recruitment of participants into the largest lung cancer screening study in Europe has been completed with a total 13,035 taking part.

UCLH clinicians and researchers will appear in a BBC One documentary on Thursday evening which highlights the harm to the body and brain caused by ultra-processed food.